Internal Medicine, Rheumatology · La Quinta, CA
NPI
1831300722
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
79215 Corporate Center Dr Ste 120
La Quinta, CA, 92253
Phone (760) 771-1111
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
140,824 services
Medicare patients, 2024
838
Average age 73
Drug cost, 2024
$8.0M
10,888 prescriptions
Company payments, 2025
$7,527
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sheri W Hsu was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 99,600 times for 34 patients. In total Sheri W Hsu billed 140,824 services in 52 codes, and Medicare paid $1.4M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-09.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 99,600 | 34 | $3.62 | $360K |
| J0897 Injection, denosumab, 1 mg | Office | 4,380 | 49 | $20.86 | $91K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 2,158 | 823 | $12.05 | $26K |
| 99214 Office E&M - Established | Office | 1,842 | 685 | $91.18 | $168K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,344 | 24 | $0.10 | $135 |
| 96401 Chemotherapy Administration | Office | 737 | 95 | $60.40 | $45K |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 401 | 175 | $25.58 | $10K |
| 99497 Care Management/Coordination | Office | 210 | 210 | $63.83 | $13K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 193 | 34 | $0.66 | $127 |
| 99204 Office E&M - New | Office | 186 | 186 | $124.32 | $23K |
| 99443 Telephone Services | Office | 151 | 96 | $94.01 | $14K |
| 96413 Chemotherapy Administration | Office | 113 | 30 | $109.79 | $12K |
| 99215 Office E&M - Established | Office | 106 | 94 | $127.60 | $14K |
| 20610 Joint Injection | Office | 62 | 39 | $52.61 | $3,262 |
| 99205 Office E&M - New | Office | 25 | 25 | $157.33 | $3,933 |
By year: 2022 $420K for 40,116 services; 2023 $468K for 53,889 services; 2024 $1.4M for 140,824 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sheri W Hsu prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 1,006 prescriptions and refills. In total Sheri W Hsu wrote 10,888 Medicare prescriptions that cost $8.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 1,006 | 2,150 | 276 | $34K |
| Hydroxychloroquine Sulfate Generic | 925 | 2,123 | 294 | $44K |
| Prednisone Generic | 832 | 1,546 | 215 | $6,465 |
| Gabapentin Generic | 579 | 1,000 | 174 | $13K |
| Alendronate Sodium Generic | 425 | 1,110 | 152 | $3,781 |
| Sulfasalazine Generic | 413 | 879 | 138 | $14K |
| Leflunomide Generic | 405 | 972 | 145 | $27K |
| Duloxetine Hcl Generic | 369 | 859 | 126 | $8,923 |
| Meloxicam Generic | 292 | 669 | 107 | $2,023 |
| Enbrel Sureclick Etanercept | 251 | 258 | 37 | $1.9M |
| Tizanidine Hcl Generic | 242 | 470 | 83 | $2,881 |
| Tramadol Hcl Generic | 239 | 239 | 48 | $1,241 |
| Folic Acid Generic | 237 | 627 | 82 | $2,006 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 205 | 205 | 37 | $4,251 |
| Humira(Cf) Pen Adalimumab | 195 | 223 | 33 | $1.6M |
Brand drugs: 1,712 claims; generic drugs: 9,160 claims; opioid claims: 504.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sheri W Hsu $7,527 ($7,527 in general payments such as food, travel and fees) from 19 companies. The largest payer was Amgen Inc. with $1,532.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 57 | $1,532 |
| Abbvie Inc. ABBV | 43 | $1,248 |
| UCB, Inc. UCB.BR | 29 | $1,162 |
| Mallinckrodt Hospital Products Inc. | 16 | $601 |
| Janssen Biotech, Inc. JNJ | 17 | $502 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $434 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $385 |
| Lilly USA, LLC LLY | 10 | $337 |
| ANI Pharmaceuticals, Inc. ANIP | 10 | $275 |
| Aurinia Pharma U.S., Inc. AUPH | 9 | $263 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.